Scarica l'app Stockscreener
1.36
1.49%
0.02
Dopo l'orario di chiusura:
1.42
0.06
+4.41%
Precedente Chiudi:
$1.34
Aprire:
$1.34
Volume 24 ore:
141.09K
Relative Volume:
0.32
Capitalizzazione di mercato:
$80.87M
Reddito:
$2.91M
Utile/perdita netta:
$-220.40M
Rapporto P/E:
-0.3736
EPS:
-3.64
Flusso di cassa netto:
$-176.15M
1 W Prestazione:
-1.45%
1M Prestazione:
-13.92%
6M Prestazione:
-86.36%
1 anno Prestazione:
-90.07%
Intervallo 1D:
$1.2962
$1.40
Intervallo di 1 settimana:
$1.29
$1.44
Portata 52W:
$1.26
$22.50
Igm Biosciences Inc Stock (IGMS) Company Profile
Nome
Igm Biosciences Inc
Settore
Industria
Telefono
650-965-7873
Indirizzo
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Confronta IGMS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IGMS
Igm Biosciences Inc
|
1.36 | 80.87M | 2.91M | -220.40M | -176.15M | -3.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
479.79 | 123.21B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.74 | 76.39B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
624.67 | 37.96B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.75 | 31.94B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
271.80 | 29.00B | 3.32B | -860.46M | -1.04B | -8.32 |
Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2025-01-10 | Downgrade | Guggenheim | Buy → Neutral |
| 2025-01-10 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2025-01-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-10 | Downgrade | Stifel | Buy → Hold |
| 2024-12-06 | Iniziato | BMO Capital Markets | Outperform |
| 2024-10-01 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-10-01 | Downgrade | Truist | Buy → Hold |
| 2024-02-09 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-11-09 | Ripresa | Jefferies | Buy |
| 2022-10-17 | Iniziato | JP Morgan | Neutral |
| 2022-08-29 | Iniziato | BofA Securities | Buy |
| 2021-12-13 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-11-05 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2021-08-26 | Iniziato | Morgan Stanley | Overweight |
| 2021-01-29 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-01-19 | Reiterato | H.C. Wainwright | Buy |
| 2020-12-22 | Downgrade | Wedbush | Outperform → Neutral |
| 2020-07-17 | Iniziato | Robert W. Baird | Outperform |
| 2020-07-01 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-28 | Iniziato | SunTrust | Buy |
| 2020-04-22 | Iniziato | Wedbush | Outperform |
| 2019-10-14 | Iniziato | Guggenheim | Buy |
| 2019-10-14 | Iniziato | Jefferies | Buy |
| 2019-10-14 | Iniziato | Piper Jaffray | Overweight |
| 2019-10-14 | Iniziato | Stifel | Buy |
Mostra tutto
Igm Biosciences Inc Borsa (IGMS) Ultime notizie
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Rating of “Reduce” from Brokerages - Defense World
IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Yahoo Finance
IGM Biosciences (IGMS) Projected to Post Quarterly Earnings on Thursday - Defense World
IGM to slash 73% of workforce, halt two drug programs - MSN
Fierce Biotech Layoff Tracker 2025: Encoded trims 29% of team; Inventiva halves staff - Fierce Biotech
Layoff Tracker: Viracta, X4 and BMS Detail Current, Upcoming Cuts - BioSpace
Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) PT at $5.50 - MarketBeat
IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $5.50 Consensus Price Target from Analysts - Defense World
Down -76.91% in 4 Weeks, Here's Why IGM Biosciences (IGMS) Looks Ripe for a Turnaround - Nasdaq
Impressive Stock Surge: IGM Biosciences, XTI Aerospace and More See Major Gains – Market - HPBL
Impressive Stock Gains Across Multiple Sectors: IGM Biosciences, XTI Aerospace, and More Surge - HPBL
IGM Biosciences stock plunges to 52-week low of $1.59 - MSN
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of IGM Biosciences, Inc.IGMS - Longview News-Journal
IGM Biosciences stock plunges to 52-week low of $1.59 By Investing.com - Investing.com Canada
Why Is IGM Biosciences Inc (NASDAQ: IGMS) Falling? - Stocks Register
Igm Biosciences Inc Azioni (IGMS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Igm Biosciences Inc Azioni (IGMS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Weber Steven | PRINCIPAL ACCOUNTING OFFICER |
Dec 16 '24 |
Sale |
7.48 |
539 |
4,032 |
31,704 |
| Decker Lisa Lynn | CHIEF BUSINESS OFFICER |
Dec 16 '24 |
Sale |
7.48 |
1,063 |
7,951 |
78,041 |
| Harler Mary Beth | Chief Executive Officer |
Dec 16 '24 |
Sale |
7.48 |
1,708 |
12,776 |
347,032 |
| Tahir Misbah | CHIEF FINANCIAL OFFICER |
Dec 16 '24 |
Sale |
7.48 |
1,708 |
12,776 |
187,653 |
0.22%
0.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):